glp-1 for crohn's Another positive association with GLP1s! New data from the 2026 ASCO Breakthrough Meeting 🔬 People with inflammatory bowel disease (Crohn's or ulcerative colitis) face a higher risk of colorectal cancer. This large GLP-1 and Gut Health: Addressing

It's a scientifically determined timeframe that balances utility with safety

Caspase inhibitors, overexpression of the anti-apoptotic Bcl-2, p53 inhibitors, and the STAT1 inhibitor epigallocatechin gallate, which can reverse Bcl-2 family equilibrium toward antiapoptosis, have been proposed as protective measures for hair cells against apoptosis caused by cisplatin (Wu et al

"Food intake reductions and increases in energetic responses by hindbrain leptin and melanotan II are enhanced in mice with POMC-specific PTP1B deficiency." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Sattar N, et al

The MAD evaluated doses ranging from 140 mg to 420 mg administered every 4 weeks on days 1, 29 and 57